{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "c0d78ad5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Key found\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "\n",
    "try:\n",
    "    GOOGLE_API_KEY = os.environ[\"GOOGLE_API_KEY\"]\n",
    "    if(GOOGLE_API_KEY):\n",
    "        print(\"Key found\")\n",
    "    else:\n",
    "        print(\"Key not found\")\n",
    "except Exception as e:\n",
    "    print(f\"Error:{e}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "a7d47b8a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ADK components imported \n"
     ]
    }
   ],
   "source": [
    "from typing import Any, Dict\n",
    "\n",
    "from google.adk.agents import Agent, LlmAgent\n",
    "from google.adk.apps.app import App, EventsCompactionConfig\n",
    "from google.adk.models.google_llm import Gemini\n",
    "from google.adk.sessions import DatabaseSessionService, InMemorySessionService\n",
    "from google.adk.runners import Runner\n",
    "from google.adk.tools.tool_context import ToolContext\n",
    "from google.genai import types\n",
    "\n",
    "print(\"ADK components imported \")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "ad32fb21",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "✅ Helper functions defined.\n"
     ]
    }
   ],
   "source": [
    "# Define helper functions that will be reused throughout the notebook\n",
    "async def run_session(\n",
    "    runner_instance: Runner,\n",
    "    user_queries: list[str] | str = None,\n",
    "    session_name: str = \"default\",\n",
    "):\n",
    "    print(f\"\\n ### Session: {session_name}\")\n",
    "\n",
    "    # Get app name from the Runner\n",
    "    app_name = runner_instance.app_name\n",
    "\n",
    "    # Attempt to create a new session or retrieve an existing one\n",
    "    try:\n",
    "        session = await session_service.create_session(\n",
    "            app_name=app_name, user_id=USER_ID, session_id=session_name\n",
    "        )\n",
    "    except:\n",
    "        session = await session_service.get_session(\n",
    "            app_name=app_name, user_id=USER_ID, session_id=session_name\n",
    "        )\n",
    "\n",
    "    # Process queries if provided\n",
    "    if user_queries:\n",
    "        # Convert single query to list for uniform processing\n",
    "        if type(user_queries) == str:\n",
    "            user_queries = [user_queries]\n",
    "\n",
    "        # Process each query in the list sequentially\n",
    "        for query in user_queries:\n",
    "            print(f\"\\nUser > {query}\")\n",
    "\n",
    "            # Convert the query string to the ADK Content format\n",
    "            query = types.Content(role=\"user\", parts=[types.Part(text=query)])\n",
    "\n",
    "            # Stream the agent's response asynchronously\n",
    "            async for event in runner_instance.run_async(\n",
    "                user_id=USER_ID, session_id=session.id, new_message=query\n",
    "            ):\n",
    "                # Check if the event contains valid content\n",
    "                if event.content and event.content.parts:\n",
    "                    # Filter out empty or \"None\" responses before printing\n",
    "                    if (\n",
    "                        event.content.parts[0].text != \"None\"\n",
    "                        and event.content.parts[0].text\n",
    "                    ):\n",
    "                        print(f\"{MODEL_NAME} > \", event.content.parts[0].text)\n",
    "    else:\n",
    "        print(\"No queries!\")\n",
    "\n",
    "\n",
    "print(\"✅ Helper functions defined.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "c898a564",
   "metadata": {},
   "outputs": [],
   "source": [
    "retry_config = types.HttpRetryOptions(\n",
    "    attempts=5,  # Maximum retry attempts\n",
    "    exp_base=7,  # Delay multiplier\n",
    "    initial_delay=1,\n",
    "    http_status_codes=[429, 500, 503, 504],  # Retry on these HTTP errors\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "eb9346a4",
   "metadata": {},
   "source": [
    "# 1.1 Stateful Agent"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "bd556043",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "App name mismatch detected. The runner is configured with app name \"default\", but the root agent was loaded from \"C:\\Users\\aarya\\Desktop\\Aaryan\\Projects\\Agents\\ai-agents-workshop\\agentenv\\Lib\\site-packages\\google\\adk\\agents\", which implies app name \"agents\".\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "✅ Stateful agent initialized!\n",
      "   - Application: default\n",
      "   - User: default\n",
      "   - Using: InMemorySessionService\n"
     ]
    }
   ],
   "source": [
    "APP_NAME = \"default\"\n",
    "USER_ID = \"default\"\n",
    "SESSION = \"default\"\n",
    "\n",
    "MODEL_NAME = \"gemini-2.5-flash-lite\"\n",
    "\n",
    "root_agent = LlmAgent(\n",
    "    name = \"text_chat_bot\",\n",
    "    model = Gemini(\n",
    "        model = \"gemini-2.5-flash-lite\",\n",
    "        retry_options = retry_config\n",
    "    ),\n",
    "    description= \"A text chatbot\"\n",
    ")\n",
    "\n",
    "session_service = InMemorySessionService()\n",
    "\n",
    "runner = Runner(agent = root_agent, app_name = APP_NAME, session_service = session_service)\n",
    "\n",
    "print(\"✅ Stateful agent initialized!\")\n",
    "print(f\"   - Application: {APP_NAME}\")\n",
    "print(f\"   - User: {USER_ID}\")\n",
    "print(f\"   - Using: {session_service.__class__.__name__}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "dec2d3d5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: stateful-agentic-session\n",
      "\n",
      "User > Hi, I am Sam! What is the capital of United States?\n",
      "gemini-2.5-flash-lite >  The capital of the United States is Washington, D.C.\n",
      "\n",
      "User > Hello! What is my name?\n",
      "gemini-2.5-flash-lite >  You told me your name is Sam!\n"
     ]
    }
   ],
   "source": [
    "await run_session(\n",
    "    runner,\n",
    "    [\n",
    "        \"Hi, I am Sam! What is the capital of United States?\",\n",
    "        \"Hello! What is my name?\",  # This time, the agent should remember!\n",
    "    ],\n",
    "    \"stateful-agentic-session\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "d1837e54",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: state-agentic-session\n",
      "\n",
      "User > What did I ask you about earlier?\n",
      "gemini-2.5-flash-lite >  I am sorry, but I do not have access to your past conversations. I can only process the current conversation. Therefore, I cannot tell you what you asked me about earlier.\n",
      "\n",
      "User > And remind me, what's my name?\n",
      "gemini-2.5-flash-lite >  I am sorry, but I do not have access to your personal information, including your name. I am a text chatbot and do not store any user data.\n"
     ]
    }
   ],
   "source": [
    "# Run this cell after restarting the kernel. All this history will be gone...\n",
    "await run_session(\n",
    "    runner,\n",
    "    [\"What did I ask you about earlier?\", \"And remind me, what's my name?\"],\n",
    "    \"state-agentic-session\",\n",
    ")  # Note, we are using same session name"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e141fcfa",
   "metadata": {},
   "source": [
    "# 1.2 Persistent Sessions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "1b25fae3",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "App name mismatch detected. The runner is configured with app name \"default\", but the root agent was loaded from \"C:\\Users\\aarya\\Desktop\\Aaryan\\Projects\\Agents\\ai-agents-workshop\\agentenv\\Lib\\site-packages\\google\\adk\\agents\", which implies app name \"agents\".\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "✅ Upgraded to persistent sessions!\n",
      "   - Database: my_agent_data.db\n",
      "   - Sessions will survive restarts!\n"
     ]
    }
   ],
   "source": [
    "chatbot_agent = LlmAgent(\n",
    "    model = Gemini(\n",
    "        model = \"gemini-2.5-flash-lite\",\n",
    "        retry_options = retry_config\n",
    "    ),\n",
    "    name = \"text_chat_bot\",\n",
    "    description = \"A text chatbot with persistent memory\"\n",
    ")\n",
    "\n",
    "db_url = \"sqlite:///my_agent_data.db\"\n",
    "session_service = DatabaseSessionService(db_url)\n",
    "\n",
    "runner = Runner(agent = chatbot_agent, app_name = APP_NAME, session_service = session_service)\n",
    "print(\"✅ Upgraded to persistent sessions!\")\n",
    "print(f\"   - Database: my_agent_data.db\")\n",
    "print(f\"   - Sessions will survive restarts!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "45bc0681",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: test-db-session-01\n",
      "\n",
      "User > Hi, I am Sam! What is the capital of the United States?\n",
      "gemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n",
      "\n",
      "User > Hello! What is my name?\n",
      "gemini-2.5-flash-lite >  Your name is Sam.\n"
     ]
    }
   ],
   "source": [
    "await run_session(\n",
    "    runner,\n",
    "    [\"Hi, I am Sam! What is the capital of the United States?\", \"Hello! What is my name?\"],\n",
    "    \"test-db-session-01\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "b66b75f1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['app_name', 'session_id', 'author', 'content']\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Sam! What is the capital of the United States?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hi Sam! The capital of the United States is Washington, D.C.\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam.\"}], \"role\": \"model\"}')\n"
     ]
    }
   ],
   "source": [
    "import sqlite3\n",
    "\n",
    "def check_data_in_db():\n",
    "    with sqlite3.connect(\"my_agent_data.db\") as connection:\n",
    "        cursor = connection.cursor()\n",
    "        result = cursor.execute(\n",
    "            \"select app_name, session_id, author, content from events\"\n",
    "        )\n",
    "        print([_[0] for _ in result.description])\n",
    "        for each in result.fetchall():\n",
    "            print(each)\n",
    "\n",
    "\n",
    "check_data_in_db()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b9e8f643",
   "metadata": {},
   "source": [
    "# 1.3 Context Compaction"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "4ab48f02",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\aarya\\AppData\\Local\\Temp\\ipykernel_2592\\3773147741.py:6: UserWarning: [EXPERIMENTAL] EventsCompactionConfig: This feature is experimental and may change or be removed in future versions without notice. It may introduce breaking changes at any time.\n",
      "  events_compaction_config=EventsCompactionConfig(\n",
      "App name mismatch detected. The runner is configured with app name \"research_app_compacting\", but the root agent was loaded from \"C:\\Users\\aarya\\Desktop\\Aaryan\\Projects\\Agents\\ai-agents-workshop\\agentenv\\Lib\\site-packages\\google\\adk\\agents\", which implies app name \"agents\".\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "✅ Research App upgraded with Events Compaction!\n"
     ]
    }
   ],
   "source": [
    "# Re-define our app with Events Compaction enabled\n",
    "research_app_compacting = App(\n",
    "    name=\"research_app_compacting\",\n",
    "    root_agent=chatbot_agent,\n",
    "    # This is the new part!\n",
    "    events_compaction_config=EventsCompactionConfig(\n",
    "        compaction_interval=3,  # Trigger compaction every 3 invocations\n",
    "        overlap_size=1,  # Keep 1 previous turn for context\n",
    "    ),\n",
    ")\n",
    "\n",
    "db_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\n",
    "session_service = DatabaseSessionService(db_url=db_url)\n",
    "\n",
    "# Create a new runner for our upgraded app\n",
    "research_runner_compacting = Runner(\n",
    "    app=research_app_compacting, session_service=session_service\n",
    ")\n",
    "\n",
    "\n",
    "print(\"✅ Research App upgraded with Events Compaction!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "0930c0fc",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: compaction_demo\n",
      "\n",
      "User > What is the latest news about AI in healthcare?\n",
      "gemini-2.5-flash-lite >  Here's a summary of the latest news and trends in AI in healthcare, covering a few key areas:\n",
      "\n",
      "**1. Advancements in Diagnostics and Imaging:**\n",
      "\n",
      "*   **AI for Early Disease Detection:** There's a lot of ongoing research and development in using AI to analyze medical images (X-rays, CT scans, MRIs, etc.) for earlier and more accurate detection of diseases like cancer, diabetic retinopathy, and Alzheimer's. Companies are developing AI algorithms that can identify subtle patterns that human radiologists might miss.\n",
      "*   **Personalized Treatment Recommendations:** AI is being used to analyze vast amounts of patient data, including genetic information, medical history, and treatment outcomes, to suggest the most effective and personalized treatment plans. This is particularly promising in areas like oncology.\n",
      "*   **Drug Discovery and Development Acceleration:** AI is revolutionizing the drug discovery process. It can sift through massive molecular datasets to identify potential drug candidates, predict their efficacy and safety, and optimize clinical trial design, significantly speeding up the time and reducing the cost of bringing new medicines to market.\n",
      "\n",
      "**2. AI in Clinical Workflow and Operations:**\n",
      "\n",
      "*   **Predictive Analytics for Patient Deterioration:** AI is being deployed to monitor patients in real-time and predict potential adverse events like sepsis, cardiac arrest, or hospital readmissions, allowing for proactive intervention.\n",
      "*   **Streamlining Administrative Tasks:** AI-powered tools are automating routine administrative tasks such as scheduling appointments, processing insurance claims, and managing electronic health records (EHRs), freeing up healthcare professionals to focus on patient care.\n",
      "*   **Virtual Assistants and Chatbots for Patient Engagement:** AI-powered chatbots are providing patients with 24/7 access to information, appointment reminders, medication management support, and even preliminary symptom assessment.\n",
      "\n",
      "**3. Emerging Trends and Challenges:**\n",
      "\n",
      "*   **Generative AI and Large Language Models (LLMs) in Healthcare:** LLMs like GPT-4 are showing immense potential in summarizing medical literature, assisting with clinical documentation, generating patient-friendly explanations of complex conditions, and even aiding in medical education. However, concerns around accuracy, bias, and the \"hallucination\" of information need careful consideration.\n",
      "*   **AI for Mental Health:** AI is being explored for early detection of mental health conditions through analyzing speech patterns, facial expressions, and text-based communication. AI-powered therapy apps and tools are also gaining traction.\n",
      "*   **Regulatory Hurdles and Ethical Considerations:** As AI becomes more integrated into healthcare, regulatory bodies (like the FDA in the US) are grappling with how to effectively evaluate and approve AI-powered medical devices and software. Ethical considerations around data privacy, algorithmic bias, accountability, and the potential for job displacement are also critical areas of discussion.\n",
      "*   **Interoperability and Data Silos:** A significant challenge remains in integrating AI systems with existing, often fragmented, healthcare IT infrastructure. Ensuring data interoperability and breaking down data silos are crucial for AI to reach its full potential.\n",
      "*   **Focus on Explainable AI (XAI):** For AI to be widely adopted by clinicians, there's a growing demand for \"explainable AI\" – systems that can provide clear and understandable reasoning behind their predictions and recommendations.\n",
      "\n",
      "**Where to find more specific news:**\n",
      "\n",
      "*   **Major Medical Journals:** JAMA, The Lancet, NEJM, Nature Medicine often publish cutting-edge research.\n",
      "*   **Healthcare Technology Publications:** Fierce Healthcare, Healthcare IT News, MedCity News, MobiHealthNews are good sources for industry news.\n",
      "*   **Tech News Outlets:** Websites like TechCrunch, The Verge, and specialized AI news sites will cover significant AI breakthroughs and company announcements.\n",
      "*   **Conferences and Webinars:** Major healthcare and AI conferences are often where new developments are announced.\n",
      "\n",
      "The field of AI in healthcare is moving incredibly fast, with new research and applications emerging constantly. It's an exciting time with the potential to truly transform how we prevent, diagnose, and treat diseases.\n"
     ]
    }
   ],
   "source": [
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"What is the latest news about AI in healthcare?\",\n",
    "    \"compaction_demo\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "93d5cf6d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: compaction_demo\n",
      "\n",
      "User > Are there any new developments in drug discovery?\n",
      "gemini-2.5-flash-lite >  Yes, absolutely! Drug discovery is one of the areas where AI is having the most profound and rapid impact. Here are some of the key new developments and trends:\n",
      "\n",
      "**1. Generative AI and De Novo Drug Design:**\n",
      "\n",
      "*   **Designing Novel Molecules from Scratch:** Generative AI models (like GANs and diffusion models) are no longer just screening existing compounds. They can now design entirely *new* molecular structures with desired properties, optimized for binding to a specific target, and even with improved pharmacokinetic profiles. This is a massive leap from traditional methods.\n",
      "*   **Targeted Drug Design:** Instead of a broad search, generative AI can be used to design molecules that are highly specific to a particular protein or biological pathway involved in a disease, potentially leading to more effective and less toxic drugs.\n",
      "\n",
      "**2. AI-Accelerated Target Identification:**\n",
      "\n",
      "*   **Uncovering New Disease Targets:** AI algorithms can analyze vast datasets of genomic, proteomic, and clinical data to identify novel biological targets that are implicated in diseases but might not have been obvious through traditional research. This opens up new avenues for therapeutic intervention.\n",
      "*   **Multi-Omics Integration:** AI is crucial for integrating and making sense of diverse \"omics\" data (genomics, transcriptomics, proteomics, metabolomics). This holistic view helps researchers understand the complex biological networks underlying diseases and identify key intervention points.\n",
      "\n",
      "**3. Enhanced Predictive Modeling for Efficacy and Safety:**\n",
      "\n",
      "*   **Predicting Drug Efficacy:** AI models can predict how well a drug candidate is likely to work *in vivo* (in a living organism) based on its molecular structure and known biological interactions. This helps prioritize candidates that are more likely to succeed in clinical trials.\n",
      "*   **Predicting Toxicity and Side Effects:** AI can also be used to predict potential toxicities and adverse drug reactions early in the development process, saving significant time and resources by weeding out compounds that are likely to fail later due to safety issues.\n",
      "*   **ADMET Prediction (Absorption, Distribution, Metabolism, Excretion, Toxicity):** Advanced AI models are improving the accuracy of predicting these crucial drug properties, which are often bottlenecks in drug development.\n",
      "\n",
      "**4. Revolutionizing Clinical Trial Design and Optimization:**\n",
      "\n",
      "*   **Patient Stratification:** AI can identify patient subgroups that are most likely to respond to a particular drug, leading to more efficient and successful clinical trials. This is particularly important for personalized medicine approaches.\n",
      "*   **Predicting Trial Success:** AI models are being developed to predict the likelihood of success for clinical trials based on historical data, trial design, and patient characteristics.\n",
      "*   **Decentralized and Digital Trials:** AI can support the management and analysis of data from decentralized or virtual clinical trials, making them more feasible.\n",
      "\n",
      "**5. AI for Repurposing Existing Drugs:**\n",
      "\n",
      "*   **Finding New Uses for Old Drugs:** AI can quickly analyze existing drug databases and scientific literature to identify drugs that might be effective for treating different diseases than they were originally approved for. This is a faster and cheaper route to new therapies.\n",
      "\n",
      "**6. Advancements in Small Molecule and Biologics Discovery:**\n",
      "\n",
      "*   **Small Molecules:** AI is excelling at designing novel small molecule drugs, which are the most common type of drug.\n",
      "*   **Biologics:** AI is also making inroads in the discovery and engineering of biologics, such as antibodies and protein-based therapies, by predicting protein structures and designing novel protein sequences.\n",
      "\n",
      "**Key Players and Companies:**\n",
      "\n",
      "Many biotech and pharmaceutical companies are heavily investing in AI for drug discovery. Some prominent examples include:\n",
      "\n",
      "*   **Insilico Medicine:** Known for its AI-driven platform for target discovery and generative AI for novel molecule design.\n",
      "*   **Exscientia:** Uses AI to identify drug targets and design novel drug candidates.\n",
      "*   **Atomwise:** Focuses on using deep learning for small molecule drug discovery.\n",
      "*   **Recursion Pharmaceuticals:** Leverages AI and automation to map cellular biology and discover potential drug candidates.\n",
      "*   **NVIDIA:** While not a drug discovery company directly, their powerful GPUs and AI platforms are foundational for many AI drug discovery efforts.\n",
      "\n",
      "**Challenges:**\n",
      "\n",
      "Despite these advances, challenges remain:\n",
      "\n",
      "*   **Data Quality and Access:** The accuracy of AI models heavily relies on high-quality, diverse, and well-annotated data.\n",
      "*   **Interpretability:** Understanding *why* an AI model makes a particular prediction or designs a specific molecule is still an area of active research (explainable AI or XAI).\n",
      "*   **Validation:** AI-generated hypotheses and molecules still require rigorous experimental validation in the lab and in clinical trials.\n",
      "*   **Regulatory Frameworks:** Adapting regulatory processes to accommodate AI-driven discoveries is an ongoing task.\n",
      "\n",
      "In summary, AI is fundamentally changing the landscape of drug discovery, making it faster, more efficient, and more targeted. We're seeing a shift from a trial-and-error approach to a more data-driven and predictive one.\n"
     ]
    }
   ],
   "source": [
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"Are there any new developments in drug discovery?\",\n",
    "    \"compaction_demo\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "88d14781",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: compaction_demo\n",
      "\n",
      "User > Tell me more about the second development you found.\n",
      "gemini-2.5-flash-lite >  You're referring to **AI for Target Identification** in drug discovery. This is a really crucial area because finding the right biological target is the first step in developing any drug. If you aim for the wrong target, the drug won't work, no matter how well-designed it is.\n",
      "\n",
      "Here's a deeper dive into how AI is revolutionizing target identification:\n",
      "\n",
      "**The Traditional Challenge:**\n",
      "\n",
      "Historically, identifying drug targets relied heavily on:\n",
      "\n",
      "*   **Hypothesis-driven research:** Scientists would form hypotheses based on existing biological knowledge and then conduct experiments to test them. This is often slow, labor-intensive, and can be limited by human biases or incomplete understanding.\n",
      "*   **Observational studies:** Observing disease patterns and trying to infer underlying biological mechanisms.\n",
      "\n",
      "This process could take years, and many promising avenues might have been missed because the technology or data analysis capabilities were insufficient to uncover them.\n",
      "\n",
      "**How AI is Changing the Game:**\n",
      "\n",
      "AI, particularly machine learning and deep learning, excels at sifting through massive, complex datasets that would be impossible for humans to analyze effectively. Here's how it's applied to target identification:\n",
      "\n",
      "1.  **Analyzing Multi-Omics Data:**\n",
      "    *   **What it is:** This involves analyzing various layers of biological information from a single sample or group of samples. This includes:\n",
      "        *   **Genomics:** The complete set of genes in an organism. AI can identify genetic mutations or variations associated with diseases.\n",
      "        *   **Transcriptomics:** The study of RNA molecules, which reveals which genes are active (expressed) and to what extent. AI can spot abnormal gene expression patterns in diseased cells.\n",
      "        *   **Proteomics:** The study of proteins, the workhorses of cells. AI can identify proteins that are over- or under-expressed, or are functioning abnormally.\n",
      "        *   **Metabolomics:** The study of small molecules (metabolites) involved in cellular processes. AI can detect metabolic shifts indicative of disease.\n",
      "    *   **AI's role:** AI algorithms can integrate these disparate data types to build a comprehensive picture of the biological state. They can identify correlations between specific genetic mutations, altered gene expression, abnormal protein levels, and disease phenotypes that might not be apparent when looking at each \"omic\" layer in isolation.\n",
      "    *   **Example:** An AI might identify a specific gene mutation (genomics) that leads to the overproduction of a particular protein (proteomics) in cancer cells, making that protein a potential target for a new cancer drug.\n",
      "\n",
      "2.  **Leveraging Electronic Health Records (EHRs) and Real-World Data (RWD):**\n",
      "    *   **What it is:** EHRs contain vast amounts of patient information, including diagnoses, medications, lab results, and even physician notes. RWD encompasses data collected outside of traditional clinical trials (e.g., from wearables, insurance claims).\n",
      "    *   **AI's role:** AI can analyze these anonymized datasets to find patterns. For instance, it can identify patient cohorts with specific conditions and look for underlying biological markers or genetic predispositions that might indicate a novel therapeutic target. It can also help identify \"off-label\" uses of existing drugs, which can point to new targets.\n",
      "    *   **Example:** An AI might analyze EHR data and discover that patients with a certain genetic profile who also develop a specific complication have a higher risk of developing a particular disease. This could suggest that a protein or pathway involved in that complication is a potential target for preventative therapies.\n",
      "\n",
      "3.  **Network Biology and Pathway Analysis:**\n",
      "    *   **What it is:** Biological systems are not just a collection of individual molecules; they are complex networks of interacting genes, proteins, and metabolites.\n",
      "    *   **AI's role:** AI can map these complex biological networks and identify key \"hubs\" or nodes that are critical for disease progression. Targeting these central nodes can have a more significant therapeutic effect than targeting a peripheral component. AI can also identify pathways that are dysregulated in disease.\n",
      "    *   **Example:** AI could map the signaling pathways involved in inflammation and identify a specific enzyme that is overactive in autoimmune diseases. This enzyme could then become a target for an anti-inflammatory drug.\n",
      "\n",
      "4.  **Literature Mining and Knowledge Graphs:**\n",
      "    *   **What it is:** The scientific literature is a treasure trove of information, but it's impossible for any human to read and synthesize it all.\n",
      "    *   **AI's role:** Natural Language Processing (NLP) and other AI techniques can mine millions of research papers, patents, and clinical trial reports to extract relationships between genes, proteins, diseases, and potential therapies. These relationships can be organized into \"knowledge graphs,\" which are structured representations of scientific knowledge that AI can query and analyze to uncover novel connections and potential targets.\n",
      "    *   **Example:** An AI might discover through literature mining that a protein implicated in one disease is also mentioned in studies related to another, seemingly unrelated disease, suggesting it could be a target for both.\n",
      "\n",
      "**Benefits of AI-Driven Target Identification:**\n",
      "\n",
      "*   **Speed:** Significantly accelerates the identification of promising targets.\n",
      "*   **Breadth:** Uncovers targets that might be missed by human intuition or traditional methods.\n",
      "*   **Accuracy:** Improves the likelihood of selecting truly relevant targets by analyzing more data and complex relationships.\n",
      "*   **Cost-Effectiveness:** By identifying better targets earlier, it reduces the wasted investment in developing drugs for ineffective targets.\n",
      "\n",
      "Companies like **Recursion Pharmaceuticals**, which uses AI to analyze millions of cellular images to understand disease biology and identify targets, and **BenevolentAI**, which builds knowledge graphs from vast scientific literature, are at the forefront of this development.\n",
      "\n",
      "In essence, AI for target identification transforms the early stages of drug discovery from a painstaking exploration into a more systematic, data-driven, and predictive process.\n"
     ]
    }
   ],
   "source": [
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"Tell me more about the second development you found.\",\n",
    "    \"compaction_demo\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "d44e8e94",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--- Searching for Compaction Summary Event ---\n",
      "\n",
      "\n",
      "✅ SUCCESS! Found the Compaction Event:\n",
      "\n",
      "  Author: user\n",
      "\n",
      "\n",
      " Compacted information: model_version=None content=None grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='1ea0d247-cb6a-4b83-92c5-b02e390472fd' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1763105881.679013, 'end_timestamp': 1763105915.924103, 'compacted_content': {'parts': [{'function_call': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_response': None, 'inline_data': None, 'text': \"The conversation began with a user asking for the latest news in AI in healthcare. The AI provided a comprehensive overview covering advancements in diagnostics and imaging, AI in clinical workflow and operations, and emerging trends and challenges such as generative AI, mental health applications, regulatory hurdles, data interoperability, and the importance of explainable AI. The AI also suggested sources for more specific news.\\n\\nThe user then inquired about new developments in drug discovery, prompting the AI to detail how AI is revolutionizing the field. Key advancements included generative AI for de novo drug design, AI-accelerated target identification, enhanced predictive modeling for efficacy and safety, improved clinical trial design, AI for drug repurposing, and progress in both small molecule and biologics discovery. Several prominent companies in AI drug discovery were mentioned.\\n\\nFinally, the user asked for more details on the second development mentioned (AI for Target Identification). The AI elaborated on the traditional challenges of target identification and explained how AI, particularly machine learning, is transforming this process. This included analyzing multi-omics data (genomics, transcriptomics, proteomics, metabolomics), leveraging EHRs and real-world data, network biology and pathway analysis, and literature mining. The AI highlighted the benefits of AI-driven target identification, such as speed, breadth, accuracy, and cost-effectiveness, and cited companies like Recursion Pharmaceuticals and BenevolentAI as leaders in this area.\\n\\n**Key Information and Decisions:**\\n\\n*   **AI in Healthcare is Broad:** The initial AI response established the wide-ranging impact of AI across diagnostics, clinical operations, and drug discovery.\\n*   **Drug Discovery is a Rapidly Evolving Area:** The AI highlighted significant recent progress in AI for drug discovery, especially generative AI and target identification.\\n*   **AI for Target Identification is Crucial:** The AI emphasized that finding the right target is fundamental to drug development and explained the multifaceted ways AI contributes to this.\\n*   **Data Integration is Key:** The discussion underscored the importance of AI in integrating and analyzing diverse datasets (multi-omics, EHRs, literature) for drug discovery.\\n\\n**Unresolved Questions or Tasks:**\\n\\nThere are no explicit unresolved questions or tasks from the user's perspective in this conversation history. The AI has provided detailed answers to the user's inquiries.\", 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='4b94c37b-1b5f-4205-980a-1cb91b279542' timestamp=1763105925.356959\n",
      "\n"
     ]
    }
   ],
   "source": [
    "final_session = await session_service.get_session(\n",
    "    app_name=research_runner_compacting.app_name,\n",
    "    user_id=USER_ID,\n",
    "    session_id=\"compaction_demo\",\n",
    ")\n",
    "\n",
    "print(\"--- Searching for Compaction Summary Event ---\\n\")\n",
    "found_summary = False\n",
    "for event in final_session.events:\n",
    "    # Compaction events have a 'compaction' attribute\n",
    "    if event.actions and event.actions.compaction:\n",
    "        print(\"\\n✅ SUCCESS! Found the Compaction Event:\\n\")\n",
    "        print(f\"  Author: {event.author}\\n\")\n",
    "        print(f\"\\n Compacted information: {event}\\n\")\n",
    "        found_summary = True\n",
    "        break\n",
    "\n",
    "if not found_summary:\n",
    "    print(\n",
    "        \"\\n❌ No compaction event found. Try increasing the number of turns in the demo.\"\n",
    "    )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "08503013",
   "metadata": {},
   "outputs": [
    {
     "ename": "PermissionError",
     "evalue": "[WinError 32] The process cannot access the file because it is being used by another process: 'my_agent_data.db'",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mPermissionError\u001b[39m                           Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[23]\u001b[39m\u001b[32m, line 5\u001b[39m\n\u001b[32m      2\u001b[39m \u001b[38;5;28;01mimport\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mos\u001b[39;00m\n\u001b[32m      4\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m os.path.exists(\u001b[33m\"\u001b[39m\u001b[33mmy_agent_data.db\u001b[39m\u001b[33m\"\u001b[39m):\n\u001b[32m----> \u001b[39m\u001b[32m5\u001b[39m     \u001b[43mos\u001b[49m\u001b[43m.\u001b[49m\u001b[43mremove\u001b[49m\u001b[43m(\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mmy_agent_data.db\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m)\u001b[49m\n\u001b[32m      6\u001b[39m \u001b[38;5;28mprint\u001b[39m(\u001b[33m\"\u001b[39m\u001b[33m✅ Cleaned up old database files\u001b[39m\u001b[33m\"\u001b[39m)\n",
      "\u001b[31mPermissionError\u001b[39m: [WinError 32] The process cannot access the file because it is being used by another process: 'my_agent_data.db'"
     ]
    }
   ],
   "source": [
    "# Clean up any existing database to start fresh (if Notebook is restarted)\n",
    "import os\n",
    "\n",
    "if os.path.exists(\"my_agent_data.db\"):\n",
    "    os.remove(\"my_agent_data.db\")\n",
    "print(\"✅ Cleaned up old database files\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2c79a200",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "agentenv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
